Acanthamoeba keratitis is a relatively uncommon infectious keratitis but is a potentially devastating corneal disease. The first case was recognized in 1973,
1 but the disease remained very rare until the 1980s, when an abrupt increase of the infection occurred in contact lens wearers.
15 16 Acanthamoeba is the genus of small, free-living protozoa that have been isolated from such environmental sources as fresh, marine, and chlorinated water; arctic ice; soil; vegetable matter; dust; and air.
17 Until the present, more than 20 species of
Acanthamoeba have been detected and classified morphologically.
18 19 Among them, only six species—
A. castellanii, A. polyphaga, A. culbertsoni, A. hatchetti, A. rhysodes, and
A. griffini—have been identified in ocular infections.
9 Among them, the most common type is
A. castellanii.
20 The reason that certain species predominantly cause corneal infection is unknown, but it may relate to such intrinsic factors as tissue adhesiveness, growth rates, and possible enzymatic activities.
21
Clinically, the features of keratitis associated with
Acanthamoeba infection resemble those observed with herpes simplex or, in some instances, with bacteria or fungi.
22 These similarities often lead to inappropriate medical treatment. Subsequent culture isolation of
Acanthamoeba can be rendered more difficult under such circumstances. Delayed diagnosis or misdiagnosis as bacterial or herpes simplex keratitis leads to extensive corneal inflammation and profound visual loss. Therefore, accurate and rapid diagnosis of
Acanthamoeba keratitis is essential for successful treatment and good prognosis.
Successful medical treatment is the goal in management of this disease and avoids the requirement for corneal transplantation. It is our experience and that of others that
Acanthamoeba keratitis diagnosed at an earlier stage can be more successfully treated medically, without resorting to keratoplasty in the setting of uncontrolled infection.
23 With increased awareness of
Acanthamoeba keratitis among clinicians and the availability of rapid diagnostic techniques, this infection is being diagnosed at an earlier stage. Laboratory diagnosis is primarily by culture of epithelial scraping samples inoculated onto NNA-coated plates spread with bacteria. Direct microscopic examination of samples is aided with stains for the cyst wall or immunostaining. A variety of topically applied therapeutic agents are thought to be effective, including propamidine isethionate, clotrimazole, PHMB, and chlorhexidine.
Some investigators found that different
Acanthamoeba species and strains differ in susceptibility to other antimicrobials at practically obtainable drug levels.
24 25 26 27 28 Theses findings normally suggest that specification is important for effective treatment and favorable prognosis. Also, given that differences in efficacy were particularly striking against different
Acanthamoeba species substantiates, our concern is about the potential importance of species identification and obtaining a successful clinical response.
28
Although species identification of
Acanthamoeba isolates from clinical samples is unlikely to be critical in chemotherapy, genetic characterization is necessary for molecular epidemiology.
9 Because of the pleomorphism of the endocyst and variation of cyst size within even a clone of
Acanthamoeba, reproducible and reliable methods should be used for species identification and molecular epidemiology. Alloenzyme and mtDNA RFLP were effective for strain identification, differentiation, or characterization because of the high polymorphism from isolate to isolate but, for the same reason, these methods were not suitable for taxonomy and systematics. Recent studies have shown that the 18S rDNA sequence analysis is useful for the taxonomic and phylogenetic study of
Acanthamoeba isolates.
7 8 However, the generation of 18S rDNA sequence data is too labor intensive and expensive for routine identification and classification of
Acanthamoeba, especially when a number of isolates must be examined. Riboprinting (i.e., PCR and RFLP of 18S rDNA), was regarded as a rapid and inexpensive method for identification of unknown
Acanthamoeba isolates from clinical and environmental samples.
6 In this study, the same result was obtained from 18S rDNA sequence analysis as from riboprinting. Furthermore, the percentage difference of the sequences among
Acanthamoeba strains was nearly the same as that estimated by riboprinting. These results support subgenus classification of
Acanthamoeba based on a riboprinting analysis.
6 Nevertheless, it may be necessary to confirm the riboprinting-based identification with 18S rDNA sequence analysis.
Acanthamoeba isolates, of which 18S rDNA sequences were closely related with
A. lugdunensis L3a, had already been reported as a causative agent of human amebic keratitis.
7 However, they were designated as
A. castellanii or
Acanthamoeba sp. This is the first report of amebic keratitis caused by
A. lugdunensis in Korea that was identified based on molecular characteristics.
A. lugdunensis was the most frequently isolated from contact lens storage cases in Korea.
29 30 31 More attention should be paid to hygienic maintenance of contact lens paraphernalia in Korea for prevention of keratitis by
A. lugdunensis.